2Chui lw Marusyk RG, Pabst HF, Measles virus spe- cific antibody in a infants in a highly vaccinated soci- ety.J Med Virol, 1991,33(3) :199-204.
3Gagneur A,Pinquier D,Aubert M,et al. Kinerics of decline of maternal measles virus-neutralizing anti- bodies in sera of infants in France in 2006. Clin Vaccine Immunol, 2008,15(12) : 1845-1850.
3Plans P, Costa J, Dominguez A. Prevalence of Protective Measles Virus Antibody Levels in Umbilical Cord Blood Samples in Catalonia, Spain [ J ]. Clin Vaccine Immunol, 2010,17 (4) : 691-694.
4Gagneur A, Pinquier D, Aubert M, et al. Kinetics of Decline of Maternal Measles Virus-Neutralizing Antibodies in Sera of Infants in France in 2006[J].Clinical And Vaccine Immunology, 2008, 15 (12) : 1845-1850.
5Lee YL, Black FL, Chen CL, et al. The optimal age for vaccination against measles in an Asiatic city, Taipei, Taiwan: reduction of vaccine induced titre by residual transplacental antibody [J]. Int J Epidemiol, 1983, 12 (3) : 340-343.
6Black FL, Berman LL, Libel M, et al. Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination [J].Bull WHO,1984,62 (2): 315-319.
